RSSCategory: Pharmaceuticals

Malaria vaccine developed by Australian scientists passes early human trials

March 29, 2017
Malaria vaccine developed by Australian scientists passes early human trials

A new malaria vaccine developed by Australian scientists has passed early human trials, marking a world-first breakthrough in vaccine development for the mosquito-borne disease that kills up to half a million people each year. The vaccine, called PlasProtecT, developed by researchers at Queensland’s Griffith University consists of inactivated human malaria parasites which have been prevented [...]

Continue Reading

New evolocumab drug more effective than statins in cutting cholesterol levels

March 20, 2017
New evolocumab drug more effective than statins in cutting cholesterol levels

A new innovative drug, called evolocumab, has been found to be more effective than the often-prescribed statins in cutting down the levels of bad cholesterol and lowering the risk of heart attacks and strokes. The positive results of the international trial means the drug could soon be used by millions of people. Around 15 million [...]

Continue Reading

Two-part vaccine shows potential for long-lasting protection against Ebola

March 15, 2017
Two-part vaccine shows potential for long-lasting protection against Ebola

A two-part vaccine from Johnson & Johnson and Danish partner Bavarian Nordic has shown promising results in offering long-lasting protection against the deadly Ebola virus. The vaccine induced a durable immune response lasting a full year in 100% of healthy volunteers vaccinated, researchers reported. “The persistence of vaccine-induced immunity to one year post-immunization is truly [...]

Continue Reading

HIV vaccine leaves five patients without need for daily drugs in early trials

February 27, 2017
HIV vaccine leaves five patients without need for daily drugs in early trials

A new development in the search for a functional HIV cure has been made in the early trials of a vaccine-based treatment that combines two new HIV vaccines with a drug usually used to treat cancer. The new treatment proved to be successful in suppressing the virus in five of the patients in what could [...]

Continue Reading

CEPI urges fast-tracking of vaccines for three potential disease outbreaks

January 20, 2017
CEPI urges fast-tracking of vaccines for three potential disease outbreaks

The Coalition for Epidemic Preparedness Innovations (CEPI), a public-private coalition that aims to derail epidemics by speeding development of vaccines, has committed US$460million to speed up vaccine development for MERS, Lassa fever and Nipah virus – three relatively little-known diseases scientists think could cause the next global health emergency. Aiming to have two new experimental [...]

Continue Reading

US CDC finds superbug resistant to all kinds of antibiotic

January 18, 2017
US CDC finds superbug resistant to all kinds of antibiotic

The US Centers for Disease Control and Prevention (CDC) report has confirmed that a 70-year-old woman from Nevada in the US has died after being infected with a superbug that is “resistant to all available antimicrobial drugs”. The victim broke her right leg during a long stay in India and had repeatedly needed hospital treatment [...]

Continue Reading

Guardant Health partners with top pharma companies to speed clinical trials

January 9, 2017
Guardant Health partners with top pharma companies to speed clinical trials

Guardant Health, an oncology-focused company based in California in the US, is partnering with leading international pharmaceutical companies to create a 500-plus-gene liquid biopsy panel that will help drug companies accelerate clinical trials and the development of targeted cancer drugs and immunotherapies. The company has entered into separate agreements with British-Swedishbio pharmaceutical company AstraZeneca, American [...]

Continue Reading

Novartis invests in potential cardiovascular therapies from Ionis

January 9, 2017
Novartis invests in potential cardiovascular therapies from Ionis

Basel, Switzerland-based multinational pharmaceutical company Novartis International AG has entered into a collaboration and option agreement with Ionis Pharmaceuticals Inc. and its subsidiary Akcea Therapeutics Inc. to license two experimental cardiovascular treatments. The investigational antisense therapies – called AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx – from the US-based companies have the potential to significantly reduce cardiovascular risk in [...]

Continue Reading

US judge favors Amgen Inc. in patent lawsuit against Sanofi, Regeneron

January 6, 2017
US judge favors Amgen Inc. in patent lawsuit against Sanofi, Regeneron

A federal judge in the state of Delaware in the US has favored California-based multinational biopharmaceutical company Amgen Inc. in a patent infringement lawsuit filed against Sanofi SA and Regeneron Pharmaceuticals, Inc. over a cholesterol drug. U.S. District Judge Sue Robinson in Delaware ordered a ban on the sales of Praluent, a cholesterol drug from [...]

Continue Reading

Quetta, Pakistan launches five-day polio campaign as officials find rare strain

January 4, 2017
Quetta, Pakistan launches five-day polio campaign as officials find rare strain

The southwestern city of Quetta, capital of the Balochistan province in Pakistan, has launched a new five-day polio immunization campaign for children under five years of age after sewage samples were found to contain a rare strain of the virus, according to local officials. Muslim clerics were also recruited by local officials to promote the [...]

Continue Reading